Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ryder

Showing results (1-10 of 224) with videos related to

Pageof 23
Sort By:
Nursing Times|December 22, 1982
Some home truthsJ Ryder
IMJ. Illinois Medical Journal|January 1, 1973
Transgrow in Winnebago countyJ Ryder
Health Manpower Management|May 27, 1999
The secret of good conversation--investing in successJ Ryder-Smith
Risk Management (New York, N.Y.)|June 10, 1983
Ford finds containing health costs is no Sunday driveP J Ryder
Lancet (London, England)|December 22, 1990
UK food legislationC J Ryder
The Lancet. Diabetes & Endocrinology|September 19, 2018
Real-world diabetes prevention: from theory to practiceRobert E J Ryder
Diabetic Medicine : a Journal of the British Diabetic Association|March 17, 2015
Neither evidence from the PROactive study nor the KPNC supports pioglitazone as a tumour promoterR E J Ryder
Diabetic Medicine : a Journal of the British Diabetic Association|October 1, 2013
The potential risks of pancreatitis and pancreatic cancer with GLP-1-based therapies are far outweighed by the proven and potential (cardiovascular) benefitsR E J Ryder
The Journal of Pharmacy and Pharmacology|December 1, 1977
A comparison of the effectiveness of several disintegrants in capsules of 4-ethoxycarbonylphenoxy-2'-pyridyl methane (BRL 10614) [proceedings]J Ryder, A Thomas
Diabetic Medicine : a Journal of the British Diabetic Association|December 5, 2014
Pioglitazone has a dubious bladder cancer risk but an undoubted cardiovascular benefitR E J Ryder
Pageof 23

Showing results (1-10 of 224) with videos related to

Sort By:
Pageof 23
Nursing Times|December 22, 1982
Some home truthsJ Ryder
IMJ. Illinois Medical Journal|January 1, 1973
Transgrow in Winnebago countyJ Ryder
Health Manpower Management|May 27, 1999
The secret of good conversation--investing in successJ Ryder-Smith
Risk Management (New York, N.Y.)|June 10, 1983
Ford finds containing health costs is no Sunday driveP J Ryder
Lancet (London, England)|December 22, 1990
UK food legislationC J Ryder
The Lancet. Diabetes & Endocrinology|September 19, 2018
Real-world diabetes prevention: from theory to practiceRobert E J Ryder
Diabetic Medicine : a Journal of the British Diabetic Association|March 17, 2015
Neither evidence from the PROactive study nor the KPNC supports pioglitazone as a tumour promoterR E J Ryder
Diabetic Medicine : a Journal of the British Diabetic Association|October 1, 2013
The potential risks of pancreatitis and pancreatic cancer with GLP-1-based therapies are far outweighed by the proven and potential (cardiovascular) benefitsR E J Ryder
The Journal of Pharmacy and Pharmacology|December 1, 1977
A comparison of the effectiveness of several disintegrants in capsules of 4-ethoxycarbonylphenoxy-2'-pyridyl methane (BRL 10614) [proceedings]J Ryder, A Thomas
Diabetic Medicine : a Journal of the British Diabetic Association|December 5, 2014
Pioglitazone has a dubious bladder cancer risk but an undoubted cardiovascular benefitR E J Ryder
Pageof 23